Aikaterini Dimakou (Agia Paraskeyi, Greece), Michael Loebinger (London, United Kingdom), Pieter Goeminne (Bornem, Belgium), Andres de Roux (Berlin, Germany)
Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis
Prasad Palani Velu (Edinburgh, United Kingdom), Prasad Palani Velu, Pallavi Bedi, Kim Turnbull, Adam T. Hill
|  |
The development and validation of the bronchiectasis health questionnaire (BHQ)
Arietta Spinou (London, United Kingdom), Arietta Spinou, Richard Siegert, Amit Patel, Kai Lee, Caroline Elston, Michael Loebinger, Robert Wilson, Rachel Garrod, Surinder Birring
| |
Non-invasive evaluation of airway inflammation in non-CF bronchiectasis
Stamatoula Tsikrika (Athens, Greece), Stamatoula Tsikrika, Katerina Dimakou, Andriana Papaioannou, George Hillas, Kostantinos Kostikas, Stelios Loukides, Spyros Papiris, Nikos Koulouris, Petros Bakakos
| |
Non CF-bronchiectasis in a Moldovan population: Etiologic, radiological, microbiological and functional profile
Oxana Munteanu (Chisihau, Republic of Moldova), Oxana Munteanu, Victor Botnaru, Doina Rusu, Nicoleta Babalici, Dumitru Chesov
| |
Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities
Zoran Arsovski (Skopje, FYROM (Macedonia)), Zoran Arsovski, Biserka Kjaeva, Dejan Dokic, Zlatica Goseva, Sava Pejkovska, Elena Janeva, Suzana Arbutina, Angela Debreslioska, Anita Arsovska
| |
Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?
Carsten Schwarz (Berlin, Germany), Carsten Schwarz, Horst Von Bernuth, Claudia Rolinck-Werninghaus, Jobst Fridolin Roehmel, Susanne Lau, Markus Becker, Maria Deja, Doris Staab
|  |
Clinico-pathological profile of adult bronchiectasis patients at a North Indian teaching hospital
Mrityunjaya Singh (Varanasi, India), Mrityunjaya Singh, Govind Narayan Srivastava, Manoj Meena, Mohit Bhatia, Shruti Singh
| |
In vitro evaluation of the Twincer colistin dry powder inhaler as a non-cough-inducing alternative to Colobreathe
Paul Hagedoorn (Groningen, Netherlands), Paul Hagedoorn, Floris Grasmeijer, Marcel Hoppentocht, Onno Akkerman, Henderik Frijlink, Anne de Boer
| |
Evaluation of inhaled dry powder tobramycin free base in non-cystic fibrosis bronchiectasis patients
Marcel Hoppentocht (Groningen, Netherlands), Marcel Hoppentocht, Onno Akkerman, Paul Hagedoorn, Jan-Willem Alffenaar, Tjip van der Werf, Huib Kerstjens, Henderik Frijlink, Anne de Boer
| |
Latent class analysis of CT patterns in pulmonary non-tuberculous mycobacterial infection
Steven Cowman (London, United Kingdom), Steven Cowman, Joseph Jacob, David Hansell, Robert Wilson, Michael Loebinger
| |
Development of a prognostic scoring system for Mycobacterium avium complex lung disease
Shogo Kumagai (Kurashiki, Japan), Shogo Kumagai, Akihiro Ito, Koji Furuuchi, Tadashi Ishida, Toru Hashimoto
| |
Azithromycin and nontuberculous mycobacteria: Is there an association?
Asha Patel (Derby, United Kingdom), Vadsala Baskaran, Asha Patel, Akhil Shial, Isabelle Van Heeswijk, Irfan Wahedna
| |
Clnico-microbiological analysis of mycobacaterium abscessus complex in Japan
Kozo Morimoto (Kiyose-shi, Tokyo, Japan), Kozo Morimoto, Akio Aono, Yoshiro Murase, Kinuyo Chikamatsu, Yuriko Igarashi, Lina Yi, Takashi Ofuji, Hiroyuki Yamada, Akiko Takaki, Atsuyuki Kurashima, Satoshi Mitarai
| |
Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease
Seong Mi Moon (Seoul, Republic of Korea), Seong Mi Moon, Hye Yun Park, Su-Young Kim, Kyeongman Jeon, Seung-Heon Lee, Chang Ki Kim, Sung Jae Shin, Won-Jung Koh
| |
Epidemiology and clinical features of nontuberculous mycobacterial lung disease in a subtropical region in Japan: Analysis with a 7-year data in two major hospitals
Hiroaki Nagano (Okinawa prefecture, Japan), Hiroaki Nagano, Takeshi Kinjou, Yuichirou Nei, Shin Yamashiro, Jirou Fujita, Tomoo KIshaba
| |
Adherence to American Thoracic Society (ATS) diagnostic criteria when treating non-tuberculous mycobacterial species over 7 years at Queen Alexandra Hospital (QAH), Portsmouth, England
Hannah Schiff (Winchester, United Kingdom), Hannah Schiff, Sophie Philpot, Andrew Achaiah, Georgina Boyes, Adriana Pereira, Ben Green
| |
Clinical features, spectrum and susceptibility pattern of non tuberculous mycobacterium isolated from pulmonary samples at tertiary care center, Pakistan
Nousheen Iqbal (Karachi, Pakistan), Nousheen Iqbal, Muhammad Irfan, Joveria Farooqi, Kauser Jabeen, Javaid Khan
| |
Aero-environmental bacteriological survey of respiratory non-tuberculosis mycobacterial disease patients
Akio Aono (Tokyo, Japan), Akio Aono, Kozo Morimoto, Yoshiro Murase, Kinuyo Chikamatsu, Yuriko Igarashi, Lina Yi, Takashi Ohfuji, Kentaro Sakashita, Hiroyuki Yamada, Akiko Takaki, Atsuyuki Kurashima, Satoshi Mitarai
| |
Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience
Valentina Conio (Pavia, Italy), Valentina Conio, Davide Piloni, Alessandro Cascina, Thomas Galasso, Barbara Fusar Poli, Francesca Cemmi, Amelia Grosso, Erica Gini, Federica Albicini, Federica Meloni, Angelo Guido Corsico
| |
Attenuated lymphocyte immune response in mycobacterium avium complex-lung disease through over-expressed programmed death-1 receptor
Chin-Chung Shu (Taipei, Taiwan), Chin-Chung Shu, Jann-Yuan Wang, Ming-Fang Wu, Chong-Jen Yu
| |